285 related articles for article (PubMed ID: 1519213)
21. Monoclonal antibody specific for tissue factor pathway inhibitor-factor Xa complex: its characterization and application to plasmas from patients with disseminated intravascular coagulation and pre-disseminated intravascular coagulation.
Ohkura N; Soe G; Kohno I; Kumeda K; Wada H; Kamikubo Y; Shiku H; Kato H
Blood Coagul Fibrinolysis; 1999 Sep; 10(6):309-19. PubMed ID: 10493212
[TBL] [Abstract][Full Text] [Related]
22. Human leukocyte elastase and cathepsin G are specific inhibitors of C5a-dependent neutrophil enzyme release and chemotaxis.
Tralau T; Meyer-Hoffert U; Schröder JM; Wiedow O
Exp Dermatol; 2004 May; 13(5):316-25. PubMed ID: 15140022
[TBL] [Abstract][Full Text] [Related]
23. Regulation of cystatin C activity by serine proteinases.
Abrahamson M; Buttle DJ; Mason RW; Hansson H; Grubb A; Lilja H; Ohlsson K
Biomed Biochim Acta; 1991; 50(4-6):587-93. PubMed ID: 1801727
[TBL] [Abstract][Full Text] [Related]
24. Activity of secreted Kunitz domain 1 variants of tissue factor pathway inhibitor.
Johnson K; Zaror I; Bauer D; Choi Y; Creasey A; Innis M
Thromb Haemost; 1998 Oct; 80(4):585-7. PubMed ID: 9798974
[TBL] [Abstract][Full Text] [Related]
25. Recombinant tissue factor pathway inhibitor enhances the binding of factor Xa to human monocytes.
Li A; Chang AC; Peer GT; Wun TC; Taylor FB
Thromb Haemost; 2001 May; 85(5):830-6. PubMed ID: 11372676
[TBL] [Abstract][Full Text] [Related]
26. Cathepsin G in human mononuclear phagocytes: comparisons between monocytes and U937 monocyte-like cells.
Senior RM; Campbell EJ
J Immunol; 1984 May; 132(5):2547-51. PubMed ID: 6562154
[TBL] [Abstract][Full Text] [Related]
27. Interaction of heparin cofactor II with neutrophil elastase and cathepsin G.
Pratt CW; Tobin RB; Church FC
J Biol Chem; 1990 Apr; 265(11):6092-7. PubMed ID: 2318847
[TBL] [Abstract][Full Text] [Related]
28. The role of catalytic cleft and exosite residues of factor VIIa for complex formation with tissue factor pathway inhibitor.
Iakhiaev A; Ruf W; Rao LV
Thromb Haemost; 2001 Mar; 85(3):458-63. PubMed ID: 11307815
[TBL] [Abstract][Full Text] [Related]
29. Inhibition of factor X activation at extracellular matrix of fibroblasts during flow conditions: a comparison between tissue factor pathway inhibitor and inactive factor VIIa.
Valentin S; Reutlingsperger CP; Nordfang O; Lindhout T
Thromb Haemost; 1995 Dec; 74(6):1478-85. PubMed ID: 8772224
[TBL] [Abstract][Full Text] [Related]
30. Interference of recombinant eglin C, a proteinase inhibitor extracted from leeches, with neutrophil-mediated platelet activation.
Renesto P; Ferrer-Lopez P; Chignard M
Lab Invest; 1990 Apr; 62(4):409-16. PubMed ID: 2159081
[TBL] [Abstract][Full Text] [Related]
31. [Inhibition of elastin hydrolysis, catalyzed by human leukocyte elastase and cathepsin G, by the Bowman-Birk type soy inhibitor].
Tikhonova TV; Gladysheva IP; Kazanskaia NF; Larionova NI
Biokhimiia; 1994 Nov; 59(11):1739-45. PubMed ID: 7873681
[TBL] [Abstract][Full Text] [Related]
32. Kinetics of the inhibition of tissue factor-factor VIIa by tissue factor pathway inhibitor.
Lindhout T; Franssen J; Willems G
Thromb Haemost; 1995 Sep; 74(3):910-5. PubMed ID: 8571320
[TBL] [Abstract][Full Text] [Related]
33. A cytosolic inhibitor of human neutrophil elastase and cathepsin G.
Thomas RM; Nauseef WM; Iyer SS; Peterson MW; Stone PJ; Clark RA
J Leukoc Biol; 1991 Dec; 50(6):568-79. PubMed ID: 1658173
[TBL] [Abstract][Full Text] [Related]
34. Neutrophil lysosomal dysfunctions in mutant C57 Bl/6J mice: interstrain variations in content of lysosomal elastase, cathepsin G and their inhibitors.
Gardi C; Cavarra E; Calzoni P; Marcolongo P; de Santi M; Martorana PA; Lungarella G
Biochem J; 1994 Apr; 299 ( Pt 1)(Pt 1):237-45. PubMed ID: 8166647
[TBL] [Abstract][Full Text] [Related]
35. Monoclonal LYM-1 antibody-dependent cytolysis by human neutrophils exposed to GM-CSF: auto-regulation of target cell attack by cathepsin G.
Ottonello L; Epstein AL; Mancini M; Dapino P; Dallegri F
J Leukoc Biol; 2004 Jan; 75(1):99-105. PubMed ID: 14525961
[TBL] [Abstract][Full Text] [Related]
36. The effect of leukocyte elastase on tissue factor pathway inhibitor.
Higuchi DA; Wun TC; Likert KM; Broze GJ
Blood; 1992 Apr; 79(7):1712-9. PubMed ID: 1558967
[TBL] [Abstract][Full Text] [Related]
37. Tissue factor pathway inhibitor is highly susceptible to chymase-mediated proteolysis.
Hamuro T; Kido H; Asada Y; Hatakeyama K; Okumura Y; Kunori Y; Kamimura T; Iwanaga S; Kamei S
FEBS J; 2007 Jun; 274(12):3065-77. PubMed ID: 17509077
[TBL] [Abstract][Full Text] [Related]
38. Survey of plant inhibitors of polymorphonuclear leukocyte elastase, pancreatic elastase, cathepsin G, cathepsin B, Hageman factor fragments, and other serine proteinases.
Hojima Y; Pisano JJ; Cochrane CG
Biochem Pharmacol; 1983 Mar; 32(6):985-90. PubMed ID: 6340694
[TBL] [Abstract][Full Text] [Related]
39. Human neutrophil elastase and cathepsin G cleavage sites in the bait region of alpha 2-macroglobulin. Proposed structural limits of the bait region.
Virca GD; Salvesen GS; Travis J
Hoppe Seylers Z Physiol Chem; 1983 Sep; 364(9):1297-302. PubMed ID: 6195065
[TBL] [Abstract][Full Text] [Related]
40. The inhibition of human neutrophil elastase and cathepsin G by peptidyl 1,2-dicarbonyl derivatives.
Mehdi S; Angelastro MR; Burkhart JP; Koehl JR; Peet NP; Bey P
Biochem Biophys Res Commun; 1990 Jan; 166(2):595-600. PubMed ID: 2302225
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
